Osteoarthritis

A Review of Mesenchymal Regenerative Medicine in the Treatment of Osteoarthritis

With nearly 30 million people in the US affected by stem cell therapy for osteoarthritis (OA), the condition continues to be among the leading causes of regenerative medicine for chronic pain and disability. Considering that advances in medical technology have increased overall life expectancy, the number of people living longer and dealing with the effects…

Regenerative Medicine Benefits for Osteoarthritis

Before the advent of regenerative medicine, patients that were suffering from osteoarthritis were forced to rely on traditional treatment options. These treatments included oral medications, cortisone injections, and surgical intervention. Fortunately, stem cells have shown to be a promising and safe alternative treatment option. Regenerative Medicine has the potential to help patients improve their quality of…

Can Stem Cells Help Osteoarthritis?

stem cell therapy for osteoarthritis (OA) is a condition in which the natural cushioning between joints breaks down eventually leading to bone-on-bone contact, pain, and loss of flexibility. OA affects roughly 30 million people in the U.S., many of whom are over the age of 60. As the U.S. population ages, the number of people…

Mesenchymal Stem Cell-Based Therapy: Potential Benefits For Osteoarthritis

Affecting over 52 million people, or nearly 25% of the adult patients, osteoarthritis (OA) continues to be the leading cause of disability for people in the United States. Occurring as a result of the protective cartilage, or articular cartilage, that cushions the ends of the bones breaking down, OA can occur in any joint, but…

Load More

Do you have questions?

We have answers. Speak with a Stemedix Care Coordinator today with no obligation. Give us a call!

Contact Us
Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.